These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1334220)

  • 1. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].
    Schuler U; Ehninger G
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():30-8. PubMed ID: 1334220
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii infection after heart transplantation].
    Vetter H; Reichenspurner H; Uberfuhr P; Netz H; Reichart B
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():56-9. PubMed ID: 1334222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayr T; Prenner G; Hipmair G; Grasser B; Freigassner M
    J Heart Lung Transplant; 1996 Mar; 15(3):314-5. PubMed ID: 8777216
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation].
    Lauchart W
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():60-4. PubMed ID: 1334223
    [No Abstract]   [Full Text] [Related]  

  • 5. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
    Schmidt GM; Kovacs A; Zaia JA; Horak DA; Blume KG; Nademanee AP; O'Donnell MR; Snyder DS; Forman SJ
    Transplantation; 1988 Dec; 46(6):905-7. PubMed ID: 2849818
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal.
    Collier AC; Corey L
    Curr Clin Top Infect Dis; 1992; 12():309-28. PubMed ID: 1322676
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical evaluation of agents used in the treatment and prevention of cytomegalovirus infection in immunocompromised patients.
    Meyers JD
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):139-42, discussion 142-3. PubMed ID: 1648819
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancytopenia with hypercellular bone marrow secondary to cytomegalovirus after cardiac transplant.
    Elkhateeb O; Jackson S; Schlech WF; Storm K; Howlett J
    J Heart Lung Transplant; 2009 Jul; 28(7):749-50. PubMed ID: 19560708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
    Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
    Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should all CMV infections after bone marrow transplantation be treated?
    Jouet JP; Draoui A; Facon T; Noel-Walter MP; Wattre P; Fenaux P; Dupriez B; Morel P; Bauters F
    Bone Marrow Transplant; 1991; 7 Suppl 2():47. PubMed ID: 1652333
    [No Abstract]   [Full Text] [Related]  

  • 12. DHPG at CMV viremia after allogeneic bone marrow transplantation. Result over a four year period (1986-1990).
    Milpied N; Harousseau JL; Moreau P; Lacroix F; Ramee JF; Billaudel S
    Bone Marrow Transplant; 1991; 7 Suppl 2():46. PubMed ID: 1652332
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Rand K; Graham-Pole J; Jansen J; Winton E; Hong R; Lazarus H; Babington R
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):138-43. PubMed ID: 2827359
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of infection after bone marrow transplantation].
    Schmeiser T
    Fortschr Med; 1991 Feb; 109(6):155-7. PubMed ID: 1646147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
    Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
    Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
    Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients.
    Volpi A; Pica F; Gentile G; Capobianchi A; Fraschetti M; Martino P
    J Infect Dis; 1999 Nov; 180(5):1747-8. PubMed ID: 10515847
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with transfusion of CMV tested blood preparations after bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen DW; Quabeck K; Thraenhart O
    Beitr Infusionsther; 1990; 26():190-3. PubMed ID: 1703827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation.
    Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.